Embed Size (px)
Citation preview
Call for AbstractsWe encourage young researchers to participate in the meeting by sending oral presentations to be discussed on the two slide seminars sessions.
Please check the guidelines on the website or kindly contact the technical secretariat for further information.
Deadline for abstract submission: September 14th, 2018
Target audienceThe meeting is aimed at pathologists-in-training and in-practice, molecular biologists, medical and surgical oncologists, and any other health care professional interested in recent advances in molecular and diagnostic pathology.
Organized by
AccreditationContinuing Education Credits requested to the Spanish National Health System.
With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid.
VenueAuditorio Rafael del PinoC/ Rafael Calvo, 39AMadrid, Spain
Meeting secretariat
Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, SpainTel.: +34 91 372 0203 · E-mail: [email protected]
Registrations: www.mdanderson.es/pathologymeeting @MDAnderson_ES
Sponsors
ADVANCES IN MOLECULAR AND
DIAGNOSTIC PATHOLOGY
2nd PATHOLOGY MEETING
Meeting Directors:Dr. Joseph Khoury
Dr. Juan Fernando García García
Madrid, October 3-5, 2018
Under the auspices of
Wednesday, October 3rd, 201814:00 - 15:00 Registration & welcome
15:00 - 15:15 Welcome / Overview Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain
15:15 - 16:05 Opening remarks and keynote lecture Dr. Peter W. T. Pisters, President, The University of Texas MD Anderson Cancer Center, Houston, USA
16:05 - 17:50 SESSION 1. Head and neck tumors Moderator: Dr. M. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain
16:05 - 16:35 Familial non-medullary thyroid tumors Dr. Jose Cameselle, Hospital Clínico Universitario Santiago de Compostela
16:35 - 17:05 Salivary gland tumors: updated classification, molecular insights, biomarkers and targeted therapy Dr. Diana Bell, The University of Texas MD Anderson Cancer Center, Houston, USA
17:05 - 17:35 Oropharyngeal cancer: two diseases in a very little space Dr. Ricard Mesía, Institut Català d'Oncologia- Badalona, Barcelona
17:35 - 17:50 Discussion
Thursday, October 4th, 2018 08:30 - 08:35 Opening remarks
08:35 - 10:20 SESSION 2. Hematolymphoid tumors Moderator Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain
08:35 - 09:20 2017 WHO Classification of Hematolymphoid Neoplasms: practical highlights for general pathologists Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA
09:20 - 10:05 Diagnostic update of aggressive B-cell lymphomas Dr. George Rassidakis, Cancercenter Karolinska, Stockholm, Sweden
10:05 - 10:20 Discussion10:20 - 10:50 Coffee Break
10:50 - 13:05 SESSION 3. Keynote symposium Moderator: Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA
10:50 - 11:20 Liquid Biopsy for Solid Tumors - Promises and Perils Dr. Mark Routbort, The University of Texas MD Anderson Cancer Center, Houston, USA
11:20 - 11:50 Predictive biomarkers for lung cancer immunotherapy Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center, Houston, USA
11:50 - 12:20 Integration of Next generation sequencing (NGS) in diagnostic molecular pathology Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain
12:20 - 12:50 Digital pathology Dr. Víctor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA
12:50 - 13:05 Discussion13:05 - 14:35 Lunch
14:35 - 16:20 SESSION 4. Gastrointestinal tumors Moderator: Dr. Santiago González Moreno, MD Anderson Cancer Center Madrid, Spain
14:35 - 15:05 Hereditary gastric cancer: knowns and unknowns Dr. Fátima Carneiro, Hospital de Sao Joao, Oporto, Portugal
15:05 - 15:35 Updates and issues in appendiceal tumors Dr. Melissa Taggart, The University of Texas MD Anderson Cancer Center, Houston, USA
15:35 - 16:05 Classification and pathology reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: perspective of the surgical oncologist
Dr. Santiago González Moreno, MD Anderson Cancer Center Madrid, Spain
16:05 - 16:20 Discussion
16:20 - 18:20 SESSION 5. Slide seminar Moderator: Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA Special seminar: four to six cases illustrating the role of molecular pathology in the clinical decision making processes
Friday, October 5th, 2018
08:30 - 09:20 Plenary Lecture - Integrating combos in routine practice of metastatic renal cell carcinoma: clinic versus pathology selection Dr. Enrique Grande, MD Anderson Cancer Center Madrid, Spain
09:20 - 10:35 SESSION 6. Genitourinary tumors Moderator: Francisco X. Real, Spanish National Cancer Center (CNIO)
09:20 - 09:50 The evolving scenario of bladder cancer classification Francisco X. Real, Spanish National Cancer Center (CNIO)
09:50 - 10:20 Molecular biology, pathology and natural history of prostate cancer: a unique malignancy Dr. Josep Lloreta, Hospital del Mar, Barcelona, Spain
10:20 - 10:35 Discussion10:35 - 11:05 Coffee Break
11:05 - 12:50 SESSION 7. Breast and gynecological tumors Moderator: Dr. Xavier Matias-Guiu, Hospital Universitari Arnau Vilanova, Lleida, Spain
11:05 - 11:35 Predictive laboratory tools for breast cancer Dr. Ayse Sahin, The University of Texas MD Anderson Cancer Center, Houston, USA
11:35 - 12:05 Mesenchymal neoplasms of the gynecological tract: current issues Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center, Houston, USA
12:05 - 12:35 Update on pathology of endometrial carcinoma Dr. Xavier Matias-Guiu, Hospital Universitari Arnau Vilanova, Lleida, Spain
12:35 - 12:50 Discussion12:50 - 14:20 Lunch
14:20 - 15:35 SESSION 8. Skin, soft tissue and bone tumors Moderator: Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA
14:20 - 14:50 Precision medicine does not leave anybody unmoved in the sarcoma field Dr. Enrique de Álava Casado, Hospital Virgen del Rocío, Seville, Spain
14:50 - 15:20 Targeted therapies and immunotherapy in melanoma. New hope for patients Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA
15:20 - 15:35 Discussion
15:35 - 17:35 SESSION 9. Slide seminar Moderator: Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain Special seminar: four to six cases illustrating the role of molecular pathology in the clinical decision making processes
17:35 - 17:50 Closing Remarks Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA
ADVANCES IN MOLECULAR AND
DIAGNOSTIC PATHOLOGY
2nd PATHOLOGY MEETING
